KEFUROX DIN 01986082
Status: Cancelled Post Market
Holder: PHARMACEUTICAL PARTNERS OF CANADA INC
Molecule: CEFUROXIME (CEFUROXIME SODIUM)
Health Canada record
| Active ingredient(s) | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DC02 CEFUROXIME |
| Original market date | 31-Dec-1993 |
| Current status date | 13-Feb-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmaceutics International Inc. — licence , not currently licensed, last inspection rating I (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CEFUROXIME (CEFUROXIME SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02241639 | CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Marketed |
| 02241638 | CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Marketed |
| 02237731 | CEFUROXIME FOR INJECTION USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market |
| 02237733 | CEFUROXIME FOR INJECTION USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market |
| 02237732 | CEFUROXIME FOR INJECTION USP | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Cancelled Post Market |
| 02422328 | CEFUROXIME FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Dormant |
| 02241640 | CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market |
| 02422298 | CEFUROXIME FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Dormant |
| 02422301 | CEFUROXIME FOR INJECTION, USP | HIKMA CANADA LIMITED | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Dormant |
| 01927264 | KEFUROX | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Cancelled Post Market |
| 01927256 | KEFUROX | PHARMACEUTICAL PARTNERS OF CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market |
| 01935828 | KEFUROX INJ PWS 750MG/ADD-VANTAGE VIAL | ELI LILLY CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market |
| 00481890 | ZINACEF INJ 1.5GM/VIAL | GLAXO CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 1.5 G | Cancelled Post Market |
| 00890936 | ZINACEF INJ 7.5GM/VIAL | GLAXO CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 7.5 G | Cancelled Post Market |
| 00497843 | ZINACEF INJ 750MG/VIAL | GLAXO CANADA INC | Powder For Solution | CEFUROXIME (CEFUROXIME SODIUM) 750 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9371 | 2008-02-12 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 8331 | 2006-10-18 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 269 | 2003-09-05 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |